KIF23 and hereditary spherocytosis: WES confirmed a KIF23 mutation, reinforcing its diagnostic value in distinguishing CDA III from other hemolytic anemias, including hereditary spherocytosis, pyruvate kinase deficiency, or others, which can share overlapping morphologic bone marrow results [3].